Exchange: NASDAQ·Updated 07:34 PM EDT
HSIC logo

HSICHenry Schein Inc.

$85.47
$0.94
(1.11%)
Today
Closed $85.47
$0.00
(0.00%)
After Hours
EarningsAug 4
Mkt Cap$9.74B
Vol1.48M
News
all
press releases
Ecolab Gears Up to Report Q2 Results: How to Play the Stock?
ECL's Q2 results are likely to benefit from strong growth engines and pricing gains, but elevated input costs may test margins and earnings momentum.
Zacks
More News
Can GE HealthCare Sustain Growth in Q2 Amid Persistent Cost Headwinds?
GE HealthCare heads into Q2 earnings season with solid revenue drivers, but inflation and tariff costs may keep margins under pressure before an expected second-half recovery.
Zacks
Will Baxter's Q2 Results Continue to Reflect Operational Headwinds?
BAX's second-quarter results may reflect pressured earnings and sales as manufacturing inefficiencies, inflation, and product holds offset steady demand across segments.
Zacks
Are Investors Undervaluing Henry Schein (HSIC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks
Labcorp Prepares to Report Q2 Earnings: What's in the Cards?
LH heads into Q2 earnings results with expectations for higher revenues and EPS, as diagnostics, specialty testing and new collaborations drive momentum.
Zacks
WST Likely to Beat Q2 Earnings Estimates: How to Play the Stock?
WST heads into Q2 earnings with expectations for revenue and EPS growth, backed by demand for biologics and GLP-1 components plus manufacturing gains.
Zacks
Henry Schein to Webcast Second Quarter 2026 Conference Call on Tuesday, August 4, 2026, at 8:00 a.m. ET
Henry Schein, Inc. (Nasdaq: HSIC), the worlds largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its second quarter 2026 financial results before the stock market opens on Tuesday, August 4, 2026, and will provide a live...
Business Wire
Will Henry Schein (HSIC) Beat Estimates Again in Its Next Earnings Report?
Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks
Edwards' Q2 Earnings on the Horizon: What's in the Cards?
EW heads into Q2 earnings results with estimates calling for double-digit revenue growth as TAVR, TMTT and Surgical heart businesses remain in focus.
Zacks
Thermo Fisher Set to Report Q2 Earnings: What's in the Cards?
TMO readies for second-quarter 2026 earnings, with growth expected across key segments as bioproduction, clinical research and new launches support results.
Zacks
<
1
2
...
>

Advertisement|Remove ads.